{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-059084","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.153726+00:00","generated_at":"2026-05-18T16:30:57.880888+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Oncology regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq compliance notice on June 26, 2025, for Listing Rule 5550(a)(2).","Common stock closing bid price was $1.00+ for 12 consecutive trading days (June 6–24, 2025).","Nasdaq considers the bid price deficiency matter closed.","Company avoids delisting; its common stock remains listed on Nasdaq Capital Market.","Ticker CTOR; compliance regained after previous bid price shortfall."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-059084","json":"https://secwatch.observer/filing/0001213900-25-059084.json","markdown":"https://secwatch.observer/filing/0001213900-25-059084.md","text":"https://secwatch.observer/filing/0001213900-25-059084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/0001213900-25-059084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/ea024719201-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T16:30:57.880888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}